Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
21
GLTO Quote, Financials, Valuation and Earnings
Last price:
$4.94
Seasonality move
:
-1.71%
Day range:
$4.66 - $4.86
52-week range:
$4.40 - $23.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.30x
Volume:
15.2K
Avg. volume:
17.6K
1-year change:
-69.04%
Market cap:
$6.2M
Revenue:
--
EPS (TTM):
-$19.20
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $36.5M | $24.6M | $38.5M | $48.2M | $23.8M | |
| Selling, General & Admin | $2.4M | $9M | $13.7M | $13M | $12.7M | |
| Other Inc / (Exp) | $2.5M | -$1.2M | $319K | -$1.1M | -$3.6M | |
| Operating Expenses | $39M | $33.6M | $52.2M | $61.2M | $36.5M | |
| Operating Income | -$39M | -$33.6M | -$52.2M | -$61.2M | -$36.5M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$36.5M | -$34.8M | -$51.8M | -$61.6M | -$38.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$36.5M | -$34.8M | -$51.8M | -$61.6M | -$38.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$36.5M | -$34.8M | -$51.8M | -$61.6M | -$38.3M | |
| Basic EPS (Cont. Ops) | -$82.41 | -$190.50 | -$51.25 | -$60.75 | -$36.00 | |
| Diluted EPS (Cont. Ops) | -$82.41 | -$190.50 | -$51.25 | -$60.75 | -$36.00 | |
| Weighted Average Basic Share | $510.5K | $182.9K | $1M | $1M | $1.1M | |
| Weighted Average Diluted Share | $510.5K | $182.9K | $1M | $1M | $1.1M | |
| EBITDA | -$38.9M | -$33.4M | -$51.8M | -$60.7M | -$35.6M | |
| EBIT | -$39M | -$33.6M | -$52.2M | -$61.2M | -$36.5M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$39M | -$33.6M | -$52.2M | -$61.2M | -$36.5M | |
| Operating Income (Adjusted) | -$39M | -$33.6M | -$52.2M | -$61.2M | -$36.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7.7M | $9.7M | $10.5M | $2.6M | $1.1M | |
| Selling, General & Admin | $2.5M | $3.2M | $3.1M | $3.3M | $2.7M | |
| Other Inc / (Exp) | -$1.5M | $208K | -$329K | -$2.8M | -$182K | |
| Operating Expenses | $10.2M | $12.9M | $13.6M | $5.9M | $3.8M | |
| Operating Income | -$10.2M | -$12.9M | -$13.6M | -$5.9M | -$3.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$11.7M | -$12.7M | -$13.7M | -$8.1M | -$3.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $7K | |
| Net Income to Company | -$11.7M | -$12.7M | -$13.7M | -$8.1M | -$3.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$11.7M | -$12.7M | -$13.7M | -$8.1M | -$3.9M | |
| Basic EPS (Cont. Ops) | -$14.61 | -$12.50 | -$13.50 | -$7.50 | -$3.39 | |
| Diluted EPS (Cont. Ops) | -$14.61 | -$12.50 | -$13.50 | -$7.50 | -$3.39 | |
| Weighted Average Basic Share | $983.4K | $1M | $1M | $1.1M | $1.1M | |
| Weighted Average Diluted Share | $983.4K | $1M | $1M | $1.1M | $1.1M | |
| EBITDA | -$10.1M | -$12.8M | -$13.5M | -$5.5M | -$3.8M | |
| EBIT | -$10.2M | -$12.9M | -$13.6M | -$5.9M | -$3.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$10.2M | -$12.9M | -$13.6M | -$5.9M | -$3.8M | |
| Operating Income (Adjusted) | -$10.2M | -$12.9M | -$13.6M | -$5.9M | -$3.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $41.5M | $36.1M | $47.6M | $31.8M | $8.2M | |
| Selling, General & Admin | $5.7M | $13.9M | $13.6M | $12.3M | $12M | |
| Other Inc / (Exp) | -$495K | $15K | -$282K | -$3.5M | -$1.9M | |
| Operating Expenses | $47.2M | $50.1M | $61.2M | $44M | $20.1M | |
| Operating Income | -$47.2M | -$50.1M | -$61.2M | -$44M | -$20.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$47.7M | -$49.9M | -$61M | -$45.9M | -$21.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$49.9M | -$61M | -$45.9M | -$21.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$47.7M | -$49.9M | -$61M | -$45.9M | -$21.2M | |
| Basic EPS (Cont. Ops) | -$87.93 | -$41.89 | -$60.25 | -$44.25 | -$19.20 | |
| Diluted EPS (Cont. Ops) | -$87.93 | -$41.89 | -$60.25 | -$44.25 | -$19.20 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$47M | -$49.7M | -$60.7M | -$43.3M | -$19.7M | |
| EBIT | -$47.2M | -$50.1M | -$61.2M | -$44M | -$20.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$47.2M | -$50.1M | -$61.2M | -$44M | -$20.1M | |
| Operating Income (Adjusted) | -$47.2M | -$50.1M | -$61.2M | -$44M | -$20.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $16.9M | $28.4M | $37.4M | $21M | $5.4M | |
| Selling, General & Admin | $5.5M | $10.4M | $10.2M | $9.5M | $8.8M | |
| Other Inc / (Exp) | -$926K | $290K | -$311K | -$2.7M | -$1.1M | |
| Operating Expenses | $22.3M | $38.8M | $47.7M | $30.5M | $14.2M | |
| Operating Income | -$22.3M | -$38.8M | -$47.7M | -$30.5M | -$14.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$23.3M | -$38.3M | -$47.6M | -$31.9M | -$14.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | $49K | |
| Net Income to Company | -$23.3M | -$38.3M | -$47.6M | -$31.9M | -$14.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$23.3M | -$38.3M | -$47.6M | -$31.9M | -$14.7M | |
| Basic EPS (Cont. Ops) | -$37.35 | -$38.00 | -$47.00 | -$30.50 | -$13.39 | |
| Diluted EPS (Cont. Ops) | -$37.35 | -$38.00 | -$47.00 | -$30.50 | -$13.39 | |
| Weighted Average Basic Share | $2M | $3M | $3M | $3.2M | $3.3M | |
| Weighted Average Diluted Share | $2M | $3M | $3M | $3.2M | $3.3M | |
| EBITDA | -$22.2M | -$38.4M | -$47.4M | -$29.9M | -$14M | |
| EBIT | -$22.3M | -$38.8M | -$47.7M | -$30.5M | -$14.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$22.3M | -$38.8M | -$47.7M | -$30.5M | -$14.2M | |
| Operating Income (Adjusted) | -$22.3M | -$38.8M | -$47.7M | -$30.5M | -$14.2M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $11.3M | $163.6M | $62.6M | $32.8M | $21.5M | |
| Short Term Investments | -- | -- | $37.6M | $27.4M | $11.7M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $1.6M | $1.7M | $805K | $774K | |
| Other Current Assets | $314K | $242K | $334K | $52K | $85K | |
| Total Current Assets | $56.1M | $169.3M | $110.1M | $63.9M | $36.8M | |
| Property Plant And Equipment | $298K | $885K | $1M | $1.2M | $325K | |
| Long-Term Investments | -- | -- | $9M | $5.8M | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $231K | $1.4M | $2M | $2.3M | $1.1M | |
| Total Assets | $56.6M | $171.6M | $122.2M | $73.2M | $38.2M | |
| Accounts Payable | $3.3M | $2.9M | $1.5M | $3.4M | $1.7M | |
| Accrued Expenses | $4.3M | $967K | $1.6M | $6.1M | $2.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $87K | $374K | $399K | $476K | $183K | |
| Other Current Liabilities | $67K | $343K | $438K | $539K | $539K | |
| Total Current Liabilities | $7.9M | $5.6M | $4.5M | $11.1M | $5.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.1M | $6.1M | $5M | $11.4M | $5.9M | |
| Common Stock | $119.6M | -- | -- | -- | -- | |
| Other Common Equity Adj | -$2.5M | $674K | -$320K | -$244K | $380K | |
| Common Equity | -$71.1M | $165.5M | $117.2M | $61.8M | $32.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $48.5M | $165.5M | $117.2M | $61.8M | $32.3M | |
| Total Liabilities and Equity | $56.6M | $171.6M | $122.2M | $73.2M | $38.2M | |
| Cash and Short Terms | $11.3M | $163.6M | $100.2M | $60.2M | $33.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $85.3M | $66.2M | $28.3M | $23.1M | $19.7M | |
| Short Term Investments | -- | $36M | $40.7M | $21.1M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $171K | $214K | $109K | $89K | |
| Other Current Assets | $288K | $194K | $77K | $134K | $133K | |
| Total Current Assets | $96.1M | $107M | $71.2M | $47.1M | $21.2M | |
| Property Plant And Equipment | $905K | $1.2M | $1.2M | $578K | $94K | |
| Long-Term Investments | -- | $25.5M | $6.8M | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $241K | $1.4M | $2.8M | $2.4M | $2.1M | |
| Total Assets | $98.2M | $135.9M | $82M | $50M | $23.4M | |
| Accounts Payable | $4.5M | $2M | $1.9M | $4.5M | $503K | |
| Accrued Expenses | $1.3M | $925K | $4.5M | $3.3M | $477K | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $316K | $428K | $418K | $352K | $32K | |
| Other Current Liabilities | $947K | $387K | $440K | $349K | $620K | |
| Total Current Liabilities | $8.3M | $5.7M | $8.9M | $12.6M | $2.4M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.9M | $6.3M | $9.3M | $12.7M | $2.4M | |
| Common Stock | $181M | -- | -- | -- | -- | |
| Other Common Equity Adj | -$315K | -$89K | -$1.9M | $46K | $665K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $58.7M | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $89.3M | $129.6M | $72.7M | $37.4M | $20.9M | |
| Total Liabilities and Equity | $98.2M | $135.9M | $82M | $50M | $23.4M | |
| Cash and Short Terms | $85.3M | $102.1M | $69.1M | $44.2M | $19.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$36.5M | -$34.8M | -$51.8M | -$61.6M | -$38.3M | |
| Depreciation & Amoritzation | $111K | $188K | $441K | $490K | $830K | |
| Stock-Based Compensation | -- | $982K | $4.5M | $5.6M | $5.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$19.3M | -$38.2M | -$52.3M | -$42.9M | -$36.9M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$326K | -- | -- | -- | -- | |
| Cash From Investing | -$326K | -- | -$48M | $12.4M | $22.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$5M | -- | -- | -- | |
| Cash From Financing | -- | $187.4M | -- | $507K | $2.9M | |
| Beginning Cash (CF) | $31.1M | $11.5M | $163.8M | $62.6M | $32.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$19.7M | $149.2M | -$100.4M | -$30M | -$11.7M | |
| Ending Cash (CF) | $11.5M | $163.8M | $62.6M | $32.8M | $21.5M | |
| Levered Free Cash Flow | -$19.3M | -$38.2M | -$52.5M | -$43.1M | -$36.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$11.7M | -$12.7M | -$13.7M | -$8.1M | -$3.9M | |
| Depreciation & Amoritzation | $82K | $118K | $104K | $367K | $60K | |
| Stock-Based Compensation | $133K | $1.2M | $1.4M | $1.5M | $681K | |
| Change in Accounts Receivable | -$36K | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.6M | -$9.2M | -$9.8M | -$8.5M | -$3.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | $7M | $8.3M | $8.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.8M | -- | -- | -- | -- | |
| Cash From Financing | $55.9M | -- | $424K | $171K | -- | |
| Beginning Cash (CF) | $36.1M | $68.6M | $29.8M | $23M | $22.9M | |
| Foreign Exchange Rate Adjustment | $2.1M | -$369K | -$348K | $120K | $467K | |
| Additions / Reductions | $47.4M | -$2.1M | -$1.1M | $2K | -$3.7M | |
| Ending Cash (CF) | $85.6M | $66.2M | $28.3M | $23.1M | $19.7M | |
| Levered Free Cash Flow | -$8.6M | -$9.2M | -$10M | -$8.5M | -$3.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$49.9M | -$61M | -$45.9M | -$21.2M | |
| Depreciation & Amoritzation | -- | $382K | $437K | $765K | $464K | |
| Stock-Based Compensation | $507K | $3.7M | $5.5M | $5.7M | $4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$49M | -$49.3M | -$36.9M | -$25.2M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$62.5M | $12.5M | $27.1M | $21.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $91.8M | $442K | $2.9M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$19.7M | -$36.4M | -$6.9M | -$3.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -$49M | -$49.5M | -$36.9M | -$25.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$23.3M | -$38.3M | -$47.6M | -$31.9M | -$14.7M | |
| Depreciation & Amoritzation | $136K | $330K | $326K | $601K | $235K | |
| Stock-Based Compensation | $507K | $3.2M | $4.2M | $4.3M | $2.9M | |
| Change in Accounts Receivable | -$865K | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23.7M | -$34.5M | -$31.5M | -$25.4M | -$13.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$62.5M | -$1.9M | $12.8M | $11.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.8M | -- | -- | -- | -- | |
| Cash From Financing | $95.6M | -- | $442K | $2.9M | -- | |
| Beginning Cash (CF) | $90.6M | $306.9M | $137.7M | $80.8M | $65.4M | |
| Foreign Exchange Rate Adjustment | $2.1M | -$740K | -$1.2M | $103K | $250K | |
| Additions / Reductions | $71.9M | -$96.9M | -$33M | -$9.8M | -$2M | |
| Ending Cash (CF) | $164.7M | $209.2M | $103.5M | $71.1M | $63.6M | |
| Levered Free Cash Flow | -$23.7M | -$34.7M | -$31.6M | -$25.4M | -$13.7M | |
Get GLTO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GLTO
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
0.30x
1.85x
Price / LTM sales
--
1.86x
Growth Metrics
GLTO
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$3.70
-$0.20
Profitability
GLTO
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Nov
1
Next Earnings Date
Apr
29
Estimated Next Earnings Date
Jan
31
Balance Sheet
GLTO
Sector
Total cash
$19.7M
$47M
Short term investments
$11.7M
$45.2M
Total assets
$38.2M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
